Economic evaluation of micafungin versus liposomal amphotericin B (LAmB) for treating patients with candidaemia and invasive candidiasis (IC) in Turkey

Micafungin was reported to be non-inferior to liposomal amphotericin B (LAmB) in treating patients with candidaemia and invasive candidiasis (IC). The current study aimed to evaluate the economic impact of using micafungin versus LAmB for treatment of candidaemia and IC in Turkey. A decision analyti...

Full description

Bibliographic Details
Published in:European Journal of Clinical Microbiology and Infectious Diseases
Main Author: Neoh C.F.; Senol E.; Kara A.; Dinleyici E.C.; Turner S.J.; Kong D.C.M.
Format: Article
Language:English
Published: Springer Verlag 2018
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049144871&doi=10.1007%2fs10096-018-3312-9&partnerID=40&md5=81f64e080624db11c3deb824749b6315

Similar Items